{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:06:32Z","timestamp":1790039192367,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:00Z","timestamp":1488499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["CDRN-1501-26692"],"award-info":[{"award-number":["CDRN-1501-26692"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000064"],"award-info":[{"award-number":["UL1TR000064"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Semant"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Drug Ontology (DrOn) is an OWL2-based representation of drug products and their ingredients, mechanisms of action, strengths, and dose forms. We originally created DrOn for use cases in comparative effectiveness research, primarily to identify historically complete sets of United States National Drug Codes (NDCs) that represent packaged drug products, by the ingredient(s), mechanism(s) of action, and so on contained in those products. Although we had designed DrOn from the outset to carefully distinguish those entities that have a therapeutic indication from those entities that have a molecular mechanism of action, we had not previously represented in DrOn any particular therapeutic indication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this work, we add therapeutic indications for three research use cases: resistant hypertension, malaria, and opioid abuse research. We also added mechanisms of action for opioid analgesics and added 108 classes representing drug products in response to a large term request from the Program for Resistance, Immunology, Surveillance and Modeling of Malaria in Uganda (PRISM) project. The net result is a new version of DrOn, current to May 2016, that represents three major therapeutic classes of drugs and six new mechanisms of action.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      A therapeutic indication of a drug product is represented as a therapeutic function in DrOn. Adverse effects of drug products, as well as other therapeutic uses for which the drug product was not designed are dispositions. Our work provides a framework for representing additional therapeutic indications, adverse effects, and uses of drug products beyond their design. Our work also validated our past modeling decisions for specific types of mechanisms of action, namely effects mediated via receptor and\/or enzyme binding. DrOn is available at:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/purl.obolibrary.org\/obo\/dron.owl\" ext-link-type=\"uri\">http:\/\/purl.obolibrary.org\/obo\/dron.owl<\/jats:ext-link>\n                      . A smaller version without NDCs is available at:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/purl.obolibrary.org\/obo\/dron\/dron-lite.owl\" ext-link-type=\"uri\">http:\/\/purl.obolibrary.org\/obo\/dron\/dron-lite.owl<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13326-017-0121-5","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T19:45:27Z","timestamp":1488483927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Therapeutic indications and other use-case-driven updates in the drug ontology: anti-malarials, anti-hypertensives, opioid analgesics, and a large term request"],"prefix":"10.1186","volume":"8","author":[{"given":"William R.","family":"Hogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Amirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baxter","family":"Bramblett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Diller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodel","family":"Enderez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Modzelewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Delcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"key":"121_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13326-016-0048-2","volume":"7","author":"J Hanna","year":"2016","unstructured":"Hanna J, Bian J, Hogan WR. An accurate and precise representation of drug ingredients. J Biomed Semantics. 2016;7:7.","journal-title":"J Biomed Semantics"},{"issue":"1","key":"121_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/2041-1480-4-44","volume":"4","author":"J Hanna","year":"2013","unstructured":"Hanna J, Joseph E, Brochhausen M, Hogan WR. Building a drug ontology based on RxNorm and other sources. J Biomed Semantics. 2013;4(1):44.","journal-title":"J Biomed Semantics"},{"key":"121_CR3","unstructured":"Hogan WR, Hanna J, Joseph E, Brochhausen M. Towards a Consistent and Scientifically Accurate Drug Ontology. In: International Conference on Biomedical Ontology 2013; Montreal, Quebec. Available at: http:\/\/ceur-ws.org\/Vol-1061\/Paper7_vdos2013.pdf 2013."},{"key":"121_CR4","first-page":"574","volume":"216","author":"G Hripcsak","year":"2015","unstructured":"Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574\u20138.","journal-title":"Stud Health Technol Inform"},{"issue":"4","key":"121_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/amiajnl-2014-002747","volume":"21","author":"RL Fleurence","year":"2014","unstructured":"Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21(4):578\u201382.","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"121_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","volume":"18","author":"SJ Nelson","year":"2011","unstructured":"Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6\u00a0years. J Am Med Inform Assoc. 2011;18(4):441\u20138.","journal-title":"J Am Med Inform Assoc"},{"issue":"11","key":"121_CR7","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/nbt1346","volume":"25","author":"B Smith","year":"2007","unstructured":"Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W, Goldberg LJ, Eilbeck K, Ireland A, Mungall CJ, et al. The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol. 2007;25(11):1251.","journal-title":"Nat Biotechnol"},{"key":"121_CR8","unstructured":"OneFlorida Clinical Research Consortium [http:\/\/onefloridaconsortium.org\/]. Accessed January 28, 2017."},{"issue":"6","key":"121_CR9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/jamia\/ocv112","volume":"22","author":"H Mo","year":"2015","unstructured":"Mo H, Thompson WK, Rasmussen LV, Pacheco JA, Jiang G, Kiefer R, Zhu Q, Xu J, Montague E, Carrell DS, et al. Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc. 2015;22(6):1220\u201330.","journal-title":"J Am Med Inform Assoc"},{"key":"121_CR10","unstructured":"E-FORCSE Home Page | Florida Department of Health [http:\/\/www.floridahealth.gov\/statistics-and-data\/e-forcse\/index.html] Accessed January 28, 2017."},{"key":"121_CR11","unstructured":"Drug Ontology Lite [http:\/\/purl.obolibrary.org\/obo\/dron\/dron-lite.owl] Accessed January 28, 2017."},{"key":"121_CR12","isbn-type":"print","volume-title":"Goodman and Gilman\u2019s manual of pharmacology and therapeutics, editors Randa Hilal-Dandan, Laurence L. Brunton","author":"R Hilal-Dandan","year":"2014","unstructured":"Hilal-Dandan R, Brunton LL, Goodman LS. Goodman and Gilman\u2019s manual of pharmacology and therapeutics, editors Randa Hilal-Dandan, Laurence L. Brunton. 2nd ed. New York: McGraw-Hill; 2014. ISBN 9780071769174.","ISBN":"https:\/\/id.crossref.org\/isbn\/9780071769174","edition":"2"},{"key":"121_CR13","doi-asserted-by":"crossref","unstructured":"Hogan WR, Hicks A, Hanna J, Amirova S, Bramblett B, Enderez R, Modzelewski T, Vasconcelos M. Opioid compound master list. Available at: https:\/\/docs.google.com\/spreadsheets\/d\/1oUETGTLq3VbazumPKSkOT5i9-Kvij0n21N8k7CNUqd8. Accessed January 28, 2017.","DOI":"10.1186\/s13326-017-0121-5"},{"key":"121_CR14","volume-title":"dron-query","author":"WR Hogan","year":"2016","unstructured":"Hogan WR. dron-query. 2016."},{"key":"121_CR15","unstructured":"Compiling and running dron query. [https:\/\/github.com\/ufbmi\/dron-query\/wiki\/Compiling-and-running-dron-query] Accessed January 28, 2017."},{"key":"121_CR16","isbn-type":"print","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/9780262527811.001.0001","volume-title":"Building ontologies with basic formal ontology","author":"R Arp","year":"2015","unstructured":"Arp R, Smith B, Spear AD. Building ontologies with basic formal ontology. Massachusetts Institute of Technology: Cambridge, Massachusetts; 2015. ISBN 9780262527811.","ISBN":"https:\/\/id.crossref.org\/isbn\/9780262527811"},{"issue":"2","key":"121_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/AO-160164","volume":"11","author":"AD Spear","year":"2016","unstructured":"Spear AD, Ceusters W, Smith B. Functions in basic formal ontology. Appl Ontol. 2016;11(2):103\u201328.","journal-title":"Appl Ontol"},{"key":"121_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2041-1480-5-29","volume":"5","author":"Y He","year":"2014","unstructured":"He Y, Sarntivijai S, Lin Y, Xiang Z, Guo A, Zhang S, Jagannathan D, Toldo L, Tao C, Smith B. OAE: the ontology of adverse events. J Biomed Semantics. 2014;5:29.","journal-title":"J Biomed Semantics"},{"key":"121_CR19","isbn-type":"print","first-page":"400","volume-title":"FOIS","author":"A Goldfain","year":"2010","unstructured":"Goldfain A, Smith B, Cowell L. Dispositions and the infectious disease ontology. In: Galton A, Mizoguci R, editors. FOIS. Amsterdam: Ios Press; 2010. p. 400\u201313. ISBN 9781614994374.","ISBN":"https:\/\/id.crossref.org\/isbn\/9781614994374"},{"key":"121_CR20","unstructured":"Smith B, Ceusters W, Goldberg LJ, Ohrbach R. Towards an Ontology of Pain and Pain-related Phenomena. In: Proceedings of the Conference on Ontology and Analytical Metaphysics. Keio University Press; 2011: 23\u201336. Available at: http:\/\/ontology.buffalo.edu\/smith\/articles\/pain.pdf."},{"issue":"Database issue","key":"121_CR21","doi-asserted-by":"publisher","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","volume":"43","author":"Gene Ontology Consortium","year":"2015","unstructured":"Gene Ontology Consortium. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43(Database issue):D1049\u20131056.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"121_CR22","doi-asserted-by":"publisher","first-page":"D415","DOI":"10.1093\/nar\/gkt1173","volume":"42","author":"DA Natale","year":"2014","unstructured":"Natale DA, Arighi CN, Blake JA, Bult CJ, Christie KR, Cowart J, D'Eustachio P, Diehl AD, Drabkin HJ, Helfer O, et al. Protein ontology: a controlled structured network of protein entities. Nucleic Acids Res. 2014;42(Database issue):D415\u2013421.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"121_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2041-1480-3-17","volume":"3","author":"Y Lin","year":"2012","unstructured":"Lin Y, He Y. Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responses. J Biomed Semantics. 2012;3(1):17.","journal-title":"J Biomed Semantics"},{"key":"121_CR24","unstructured":"Brochhausen M, Schneider J, Malone D, Empey PP, Hogan WR, Boyce RD. Towards a foundational representation of potential drug- drug interaction knowledge. In: Joint Proceedings of The First International Workshop on Drug Interaction Knowledge Representation (DIKR 2014), The Second International Workshop on Definitions in Ontologies (IWOOD 2014), and The Starting an OBI-based Biobank Ontology Workshop (OBIB 2014), co-located with 5th International Conference on Biomedical Ontologies (ICBO2014); Houston, Texas. CEUR Workshop Proceedings 2014: 16\u201331. Available at: http:\/\/ceur-ws.org\/Vol-1309\/paper2.pdf."}],"container-title":["Journal of Biomedical Semantics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13326-017-0121-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13326-017-0121-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13326-017-0121-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:28:48Z","timestamp":1790036928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13326-017-0121-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["121"],"URL":"https:\/\/doi.org\/10.1186\/s13326-017-0121-5","relation":{},"ISSN":["2041-1480"],"issn-type":[{"value":"2041-1480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,3]]},"assertion":[{"value":"11 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"10"}}